Etter kommunikasjon med selskapet kommer aksjene neste uke!
En del trege folk bla fra utlandet som ikke har betalt enda! 😵💫
Fra Verrica i dag:
“Looking ahead, this quarter we expect to announce Phase 2 results from our lead pipeline candidate, VP-315, which is being evaluated for the treatment of basal cell carcinoma. As a potential first-in-class oncolytic peptide, VP-315 is designed to have a direct killing activity of the cancer cells, and also to stimulate the immune system to recognize, infiltrate, and attack the cancer. We expect to share data from the Phase 2 study later this quarter, and we are excited about VP-315’s potential to provide an important treatment alternative for the thousands of patients who are diagnosed each year with BCC.”
3 Likes
Grei oppgang på verrica idag (14%). Får håpe det smitter over på Lytix etterhvert. Krysser fingrene for at verrica starter fase 3 etterhvert.
2 Likes
Avsluttet med 20% opp!
Det kommer til å smitte LYTIX i morgen 
drdr kom meg i forkjøpet. Kan leggje til at volumet var stort. Lovande.
2 Likes
Grei oppgang på lytix idag og meget frekk oppgang på verrica så langt idag. Begynner det endelig å løsne?
Spent på kursutviklingen når de nye aksjene kommer i markedet.
1 Like
Verrica stiger pga overraskende gode Q1 salgstall av Ycanth som ikke har noe med Lytix å gjøre.
De sier (gjentar) om Vp-315:
“Looking ahead, this quarter we expect to announce Phase 2 results from our lead pipeline candidate, VP-315, which is being evaluated for the treatment of basal cell carcinoma. As a potential first-in-class oncolytic peptide, VP-315 is designed to have a direct killing activity of the cancer cells, and also to stimulate the immune system to recognize, infiltrate, and attack the cancer. We expect to share data from the Phase 2 study later this quarter, and we are excited about VP-315’s potential to provide an important treatment alternative for the thousands of patients who are diagnosed each year with BCC.”
Mid Juni har de hintet om tidligere…… så innen 40 dager har vi svaret vi trenger for å se om det blir gull eller tull med Lytix også… 
3 Likes
1 Like
5 Likes
Rekdal virker entusiastisk. Krysser fingrene for at studiene til både Verrica og Lytix leverer.
https://tv.finansavisen.no/m/673hdzWe
3 Likes
Enig! Han virket veldig sikker og stolt 
1 Like
God fart i dag. +14,29%
1 Like
Du klarte å jinxe det 
endte på 1,59% opp.
God helg
1 Like
Rekdal er like selvsikker her og:
2 Likes
Kanskje verrica vil presentere data i uken som kommer?
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.
Jefferies Global Healthcare Conference, New York, June 6, 2024.
Event details:
Date: Thursday, June 6, 2024
Time: 3:30 pm ET
Location: New York, NY
Participants may access a live webcast of the event by clicking the link here.
The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at www.verrica.com. A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event."
1 Like
Jeg er full-lastet 
1 Like
Ref Jefferies Global Healthcare Conference nå i kveld, så “sklir” muligens
Top Line resultater fra VP-315 over til starten av juli - blir spennende selv med litt ekstra venting hvis avlesning blir utsatt noen dager!
2 Likes